Related Experiment Video
Updated: Apr 11, 2026

06:04
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
717
Preventing coronary occlusion with a retrievable aortic valve
Raul Moreno1, Maria Del Carmen Monedero1, Santiago Jiménez-Valero1
1Hospital La Paz, Madrid, Spain.
Summary
No abstract available in PubMed .
Related Concept Videos
Aortic Regurgitation III: Medical Management
559
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
559
Coronary Artery Disease V: Interprofessional Care
421
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
421

